This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
52 Week High: Archive
Assurant, Inc. (AIZ) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Assurant (AIZ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AIZPositive Net Change HGNo Net Change
earnings-surprise price-change style-scores valuation
Belden Inc (BDC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Belden (BDC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BDCPositive Net Change
earnings-surprise price-change style-scores valuation
Criteo S.A. (CRTO) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Criteo (CRTO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CRTONegative Net Change RNGPositive Net Change
earnings-surprise price-change style-scores valuation
Agnico Eagle Mines Limited (AEM) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Agnico (AEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AEMNegative Net Change GOLDNegative Net Change
earnings-surprise price-change style-scores valuation
Barrick Gold Corporation (GOLD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Barrick Gold (GOLD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
GOLDNegative Net Change IAGNegative Net Change
earnings-surprise price-change style-scores valuation
Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
RMTINegative Net Change
earnings-surprise price-change style-scores valuation
SharkNinja, Inc. (SN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
SharkNinja, Inc. (SN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SNNegative Net Change LZBNegative Net Change
earnings-surprise price-change style-scores valuation
Atmus Filtration Technologies Inc. (ATMU) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Atmus Filtration (ATMU) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ATMUNegative Net Change
earnings-surprise price-change style-scores valuation
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AXGNNegative Net Change VCYTNegative Net Change
earnings-surprise price-change style-scores valuation
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BWAYPositive Net Change
earnings-surprise price-change style-scores valuation
Bright Horizons Family Solutions Inc. (BFAM) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Bright Horizons (BFAM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BFAMNegative Net Change LRNNegative Net Change
earnings-surprise price-change style-scores valuation
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CLBTNegative Net Change VLTOPositive Net Change
earnings-surprise price-change style-scores valuation
Dole PLC (DOLE) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Dole (DOLE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DOLENegative Net Change
earnings-surprise price-change style-scores valuation
Sylvamo Corporation (SLVM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Sylvamo (SLVM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SLVMNegative Net Change
earnings-surprise price-change style-scores valuation
Genpact Limited (G) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Genpact (G) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
GPositive Net Change
earnings-surprise price-change style-scores valuation
The Progressive Corporation (PGR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Progressive (PGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PGRNegative Net Change WRBNegative Net Change
earnings-surprise price-change style-scores valuation
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DVANegative Net Change PNTGPositive Net Change
earnings-surprise price-change style-scores valuation
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
THCPositive Net Change UHSPositive Net Change
earnings-surprise price-change style-scores valuation
Veracyte, Inc. (VCYT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Veracyte (VCYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
VCYTNegative Net Change TMDXNegative Net Change
earnings-surprise price-change style-scores valuation
CLEAR Secure, Inc. (YOU) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Clear Secure (YOU) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
YOUNegative Net Change ALLEPositive Net Change
earnings-surprise price-change style-scores valuation
Boot Barn Holdings, Inc. (BOOT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Boot Barn (BOOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BOOTNegative Net Change AEONegative Net Change
earnings-surprise price-change style-scores valuation
Clover Health Investments, Corp. (CLOV) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Clover Health Investments (CLOV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CLOVNegative Net Change
earnings-surprise price-change style-scores valuation
Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UHSPositive Net Change THCPositive Net Change
earnings-surprise price-change style-scores valuation
ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Adma Biologics (ADMA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ADMANegative Net Change EXELNegative Net Change
earnings-surprise price-change style-scores valuation
Personalis, Inc. (PSNL) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Personalis (PSNL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PSNLNegative Net Change
earnings-surprise price-change style-scores valuation